OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Trends in lipid-modifying agent use in 83 countries
Joseph E. Blais, Yue Wei, Kevin K.W. Yap, et al.
Atherosclerosis (2021) Vol. 328, pp. 44-51
Open Access | Times Cited: 82
Joseph E. Blais, Yue Wei, Kevin K.W. Yap, et al.
Atherosclerosis (2021) Vol. 328, pp. 44-51
Open Access | Times Cited: 82
Showing 51-75 of 82 citing articles:
Effectiveness of Simvastatin Versus Gemfibrozil for Primary Prevention of Cardiovascular Events: A Retrospective Cohort Study of 223,699 Primary Care Patients
Joseph E. Blais, Xuxiao Ye, Eric Yuk Fai Wan, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 11, pp. 987-997
Closed Access | Times Cited: 5
Joseph E. Blais, Xuxiao Ye, Eric Yuk Fai Wan, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 11, pp. 987-997
Closed Access | Times Cited: 5
Significance of stressor media on the stability of statins: a critical assessment
Dimple S. Lalchandani, Laltanpuii Chenkual, Mahindran Mariappayan, et al.
Chemical Papers (2022) Vol. 76, Iss. 10, pp. 6047-6071
Closed Access | Times Cited: 4
Dimple S. Lalchandani, Laltanpuii Chenkual, Mahindran Mariappayan, et al.
Chemical Papers (2022) Vol. 76, Iss. 10, pp. 6047-6071
Closed Access | Times Cited: 4
National Trends in Statin Use in Lithuania from 2010 to 2021
Gytis Makarevičius, E. Rinkūnienė, Jolita Badarienė
Medicina (2022) Vol. 59, Iss. 1, pp. 37-37
Open Access | Times Cited: 4
Gytis Makarevičius, E. Rinkūnienė, Jolita Badarienė
Medicina (2022) Vol. 59, Iss. 1, pp. 37-37
Open Access | Times Cited: 4
Statin Intolerance: An Overview for Clinicians
Stanisław Surma, Joanna Lewek, Peter E. Penson, et al.
Contemporary diabetes (2023), pp. 597-635
Open Access | Times Cited: 2
Stanisław Surma, Joanna Lewek, Peter E. Penson, et al.
Contemporary diabetes (2023), pp. 597-635
Open Access | Times Cited: 2
A systematic review and meta-analysis of the effect of statin treatment on sVCAM-1 and sICAM-1
Angelo Zinellu, Arduino A. Mangoni
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 5, pp. 601-620
Open Access | Times Cited: 3
Angelo Zinellu, Arduino A. Mangoni
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 5, pp. 601-620
Open Access | Times Cited: 3
Trends in myocardial infarction and coronary revascularisation procedures in Australia, 1993–2017
Richard Lin, Celine Gallagher, Samuel J. Tu, et al.
Heart (2022) Vol. 109, Iss. 4, pp. 283-288
Closed Access | Times Cited: 3
Richard Lin, Celine Gallagher, Samuel J. Tu, et al.
Heart (2022) Vol. 109, Iss. 4, pp. 283-288
Closed Access | Times Cited: 3
Low-density lipoprotein cholesterol response to statins according to comorbidities and co-medications: A population-based study
Giulia Corn, Marie Lund, Niklas Worm Andersson, et al.
American Heart Journal (2024) Vol. 274, pp. 102-112
Open Access
Giulia Corn, Marie Lund, Niklas Worm Andersson, et al.
American Heart Journal (2024) Vol. 274, pp. 102-112
Open Access
Protective Effect of Lipid-Modifying Medication on Natural and Suicide Mortality in Bipolar Disorder
Pao‐Huan Chen, Shang‐Ying Tsai, Po‐Yu Chen, et al.
(2024)
Closed Access
Pao‐Huan Chen, Shang‐Ying Tsai, Po‐Yu Chen, et al.
(2024)
Closed Access
Serbia: Policy Response to Demographic Challenges
Mirjana Rašević, Marko Galjak
European studies of population (2024), pp. 153-178
Closed Access
Mirjana Rašević, Marko Galjak
European studies of population (2024), pp. 153-178
Closed Access
Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions
Wei-Ming Cheng, Po-Chen Li, Minh Tran-Binh Nguyen, et al.
Research Square (Research Square) (2024)
Open Access
Wei-Ming Cheng, Po-Chen Li, Minh Tran-Binh Nguyen, et al.
Research Square (Research Square) (2024)
Open Access
Association between genetic polymorphisms and other attributing factors with lipid profiles among statin users: a cross-sectional retrospective study
Amirul Faez Shamsudin, Sarina Sulong, Imran Ahmad, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access
Amirul Faez Shamsudin, Sarina Sulong, Imran Ahmad, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access
ToF-SIMS imaging shows specific lipophilic vitamin alterations in chronic reprotoxicity caused by the emerging contaminant Pravastatin in Gammarus fossarum
Tingting Fu, Valentina Calabrese, Sarah Bancel, et al.
Aquatic Toxicology (2024) Vol. 271, pp. 106935-106935
Closed Access
Tingting Fu, Valentina Calabrese, Sarah Bancel, et al.
Aquatic Toxicology (2024) Vol. 271, pp. 106935-106935
Closed Access
Trends in statin utilization and ischemic heart disease mortality in Lithuania and Sweden, 2000–2020
Indrė Trečiokienė, Kamile Daukintyte, Paul Hjemdahl, et al.
Upsala Journal of Medical Sciences (2024) Vol. 129, pp. e10412-e10412
Open Access
Indrė Trečiokienė, Kamile Daukintyte, Paul Hjemdahl, et al.
Upsala Journal of Medical Sciences (2024) Vol. 129, pp. e10412-e10412
Open Access
Achievement of LDL‐Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA‐AP Study
Sergio Cinza‐Sanjurjo, Vivencio Barrios, David Fierro-González, et al.
Cardiovascular Therapeutics (2024) Vol. 2024, Iss. 1
Open Access
Sergio Cinza‐Sanjurjo, Vivencio Barrios, David Fierro-González, et al.
Cardiovascular Therapeutics (2024) Vol. 2024, Iss. 1
Open Access
Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
Sandy Maumus-Robert, Ana Jarne‐Munoz, Alexandre Pariente, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 1
Sandy Maumus-Robert, Ana Jarne‐Munoz, Alexandre Pariente, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 1
National Trends in the Use of State-Reimbursed Lipid-Lowering Medications in Latvia (2012–2021)
Arturs Praskilevics, Inga Urtāne, Gustavs Latkovskis
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6390-6390
Open Access | Times Cited: 1
Arturs Praskilevics, Inga Urtāne, Gustavs Latkovskis
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6390-6390
Open Access | Times Cited: 1
Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens
Zizo Lusiki, Dirk Blom, Nyarai D. Soko, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 28, Iss. 6, pp. 261-279
Open Access | Times Cited: 1
Zizo Lusiki, Dirk Blom, Nyarai D. Soko, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 28, Iss. 6, pp. 261-279
Open Access | Times Cited: 1
Overall and sex-specific effect of berberine for dyslipidemia: systematic review and meta-analysis of placebo-controlled trials
Joseph E. Blais, Xin Huang, Jie Zhao
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Joseph E. Blais, Xin Huang, Jie Zhao
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
South Asian ethnicity: What can we do to make this risk enhancer a risk equivalent?
Kartik Gupta, Mahmoud Al Rifai, Aliza Hussain, et al.
Progress in Cardiovascular Diseases (2022) Vol. 75, pp. 21-32
Closed Access | Times Cited: 2
Kartik Gupta, Mahmoud Al Rifai, Aliza Hussain, et al.
Progress in Cardiovascular Diseases (2022) Vol. 75, pp. 21-32
Closed Access | Times Cited: 2
Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety
Aymen Shatnawi, Zourayz Kamran, Qusai Y. Al–Share
Personalized Medicine (2022) Vol. 20, Iss. 1, pp. 65-86
Closed Access | Times Cited: 2
Aymen Shatnawi, Zourayz Kamran, Qusai Y. Al–Share
Personalized Medicine (2022) Vol. 20, Iss. 1, pp. 65-86
Closed Access | Times Cited: 2
Effect of statins on risk and mortality of urologic malignancies: Protocol of an umbrella review
Xinyu Zhai, Pengsheng Yi, Xitao Wang, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0264076-e0264076
Open Access | Times Cited: 1
Xinyu Zhai, Pengsheng Yi, Xitao Wang, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0264076-e0264076
Open Access | Times Cited: 1
Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis
Kuan Peng, Joseph E. Blais, Nicole Pratt, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 1
Kuan Peng, Joseph E. Blais, Nicole Pratt, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 1
Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
Lijun Zhu, Yangliang Fang, Beibei Gao, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Lijun Zhu, Yangliang Fang, Beibei Gao, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Statin Use and the Risk of All-cause Mortality
Jae Hyun Bae
Korean Journal of Medicine (2023) Vol. 98, Iss. 1, pp. 4-10
Open Access
Jae Hyun Bae
Korean Journal of Medicine (2023) Vol. 98, Iss. 1, pp. 4-10
Open Access
